Meeting Information
Birth defects and reproductive and developmentally-mediated disorders constitute a major public health concern in the world today. Human development can be affected not only by drugs and chemicals but also by diet, genetics, maternal health, and socioeconomic factors. The Society for Birth Defects Research and Prevention strives to understand and protect against potential hazards to developing embryos, fetuses, children, and adults by bringing together scientific knowledge from diverse fields.
The robust scientific program represents active, timely research areas of high relevance to public health and significant usefulness to researchers in the fields of birth defects research and birth defects surveillance.
More InformationMake plans to attend the 62nd Annual Meeting. Discounted early bird rates are available through March 31. The Annual Meeting and Education Courses will take place in-person and will include a curated virtual experience to make remote participation possible in the event a registrant cannot attend in person. Once registered, expected mode of attendance (in person or remote) may be changed up until May 15.
Students and postdoctoral fellows who submit abstracts and are accepted for poster or platform presentation may apply for Travel Awards, attend a Professional Development Workshop, and participate in a variety of informal social and scientific discussion and networking events.
-
Sponsors
Annual Meeting Sponsorship makes visible an organization’s commitment to supporting new and established scientists in disciplines that are of clear importance to the health and well-being of mothers and children.
-
Sister Societies
The Society for Birth Defects Research and Prevention will once again meet concurrently with our Sister Societies, the Developmental Neurotoxicology Society (DNTS) and Organization of Teratology Information Specialists (OTIS), making possible joint scientific sessions and ample networking opportunities.
-
Exhibitors
Join us as an Exhibitor! The Annual Meeting brings together 300+ scientists, administrators, and managers from industry, academia, government and regulatory agencies to discuss the most up-to-date developments in congenital (birth) defects including their nature, cause, mechanisms, and prevention. Attendees represent the disciplines of pediatrics, anatomy, epidemiology, pharmacology and industrial toxicology, developmental biology, obstetrics, pathology, and genetics.